NCT07218055 Assessment of Music Experiences in Navigating Depression Part 2
| NCT ID | NCT07218055 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Condition | Depression |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-09-08 |
| Primary Completion | 2026-08-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-09-08 with a primary completion date of 2026-08-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is again looking at the use of music and music therapy experiences in navigating depression. The researchers will provide 11 sessions of music therapy and half will be followed by recitals at the Third Street School Music Settlement where the kids enrolled in our study will observe and interact with the performers and discuss and reflect on anxiety and performance and how sharing personal creativity affects them intra and interpersonally.
Eligibility Criteria
Inclusion Criteria: * Must indicate depression -or symptoms thereof by parent in writing * We are including children only in Amend II Exclusion Criteria: \- none
Contact & Investigator
Joanne V Loewy, D.A., LCAT, MT-BC
STUDY CHAIR
Icahn School of Medicine at Mount Sinai
Frequently Asked Questions
Who can join the NCT07218055 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 15 Years, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07218055 currently recruiting?
Yes, NCT07218055 is actively recruiting participants. Contact the research team at Shantelena.Mouzon@mountsinai.org for enrollment information.
Where is the NCT07218055 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT07218055 clinical trial?
NCT07218055 is sponsored by Icahn School of Medicine at Mount Sinai. The principal investigator is Joanne V Loewy, D.A., LCAT, MT-BC at Icahn School of Medicine at Mount Sinai. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.